gold has been researched along with decitabine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ma, H; Wang, J; Zhu, Z | 1 |
| Courcelle, M; Djaker, N; Palama, T; Sahli, F; Savarin, P; Spadavecchia, J | 1 |
2 other study(ies) available for gold and decitabine
| Article | Year |
|---|---|
Label-free real-time detection of DNA methylation based on quartz crystal microbalance measurement.
Topics: Azacitidine; Cyclin-Dependent Kinase Inhibitor p16; Decitabine; DNA; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Primase; Gold; Hep G2 Cells; HT29 Cells; Humans; Immobilized Nucleic Acids; Quartz Crystal Microbalance Techniques; Receptor, Galanin, Type 2 | 2013 |
Temozolomide, Gemcitabine, and Decitabine Hybrid Nanoconjugates: From Design to Proof-of-Concept (PoC) of Synergies toward the Understanding of Drug Impact on Human Glioblastoma Cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Decitabine; Deoxycytidine; Drug Delivery Systems; Drug Liberation; Drug Resistance, Neoplasm; Drug Synergism; Gemcitabine; Glioblastoma; Gold; Humans; Magnetic Resonance Spectroscopy; Metal Nanoparticles; Nanoconjugates; Proof of Concept Study; Spectrophotometry, Ultraviolet; Temozolomide | 2020 |